Skip Navigation



ToxSci Advance Access published online on March 20, 2008

Toxicological Sciences, doi:10.1093/toxsci/kfn059
This Article
Right arrow Advance Access manuscript (PDF)
Right arrow Supplementary Data
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Peden-Adams, M. M.
Right arrow Articles by Keil, D. E.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Peden-Adams, M. M.
Right arrow Articles by Keil, D. E.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2008. Published by Oxford University Press on behalf of the Society of Toxicology. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

SUPPRESSION OF HUMORAL IMMUNITY IN MICE FOLLOWING EXPOSURE TO PERFLUOROOCTANE SULFONATE (PFOS)

Margie M. Peden-Adams*,{gamma},{dagger},{ddagger}, Jennifer M. Keller§, Jackie G. EuDaly*,{dagger},{ddagger}, Jennifer Berger, Gary S. Gilkeson{dagger},| and Deborah E. Keil

{gamma} Department of Pediatrics, Medical University of South Carolina, Charleston, SC, USA {dagger} Department of Medicine/Rheumatology & Immunology, Medical University of South Carolina, Charleston, SC, USA {ddagger} Marine Biomedicine and Environmental Science Center, Medical University of South Carolina, Charleston, SC, USA § National Institute of Standards and Technology, Hollings Marine Laboratory, Charleston, SC, USA Clinical Laboratory Sciences, University of Nevada Las Vegas, Las Vegas NV, USA | Medical Research Service, Ralph Johnson VAMC, Charleston, SC, USA

* Author to Whom Correspondence should be addressed: Margie M. Peden-Adams, Ph.D., MUSC, 221 Ft. Johnson Rd., Charleston, SC 29412, Phone: 843-762-8551, Fax: 843-762-8700, Email: pedenada{at}musc.edu, Email: pedenadams{at}hotmail.com

Received January 25, 2008; revision received March 6, 2008; accepted March 6, 2008


   Abstract

Adult male and female B6C3F1 mice were exposed to perfluorooctane sulfonate (PFOS) daily via gavage for 28 days (0, 0.005, 0.05, 0.1, 0.5, 1 or 5 mg/kg total administered dose [TAD]). Following exposure, various immune parameters were assessed and serum PFOS concentrations were determined. Lymphocyte proliferation was not altered in either gender. NK-cell activity was increased compared to control at 0.5, 1, and 5 mg/kg TAD in male mice but was not altered in female mice. At these treatment levels, splenic T-cell immunophenotypes were minimally altered in females, but all T-cell subpopulations were significantly modulated in males beginning at 0.1 mg/kg TAD. The sheep red blood cell (SRBC) plaque-forming cell response (PFC) was suppressed in male mice beginning at 0.05 mg/kg TAD and in females at 0.5 mg/kg TAD. Serum TNP-specific IgM titers were also decreased by PFOS after TNP-LPS challenge suggesting that the humoral immune effects may be attributed to the B-cell rather than T-cell since both T-dependent (SRBC) and T-independent (TNP-LPS) antigens result in suppressed IgM production. Based on the PFC response, the LOEL for males was 0.05 mg/kg TAD [ED50 = 0.021 mg/kg TAD] and for females was 0.5 mg/kg TAD [ED50 = 0.59 mg/kg TAD]. Measured PFOS serum concentrations at these dose levels were 91.5 + 22.2 ng/g and 666 + 108 ng/g (mean + SD), respectively. The male LOEL serum level was approximately 14-fold lower than reported mean blood levels from occupationally exposed humans and fell in the upper range of concentrations reported for the general population. Overall, this study provides a profile of PFOS immunotoxicity showing effects at levels reported in humans and identifies the B-cell as a potential target.

Key Words: PFOS; immunotoxicity; immune; humoral immunity; PFC assay; TNP-LPS; serum levels.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.